171 related articles for article (PubMed ID: 16273277)
1. Anti-angiogenic effects of Hypericin-photodynamic therapy in combination with Celebrex in the treatment of human nasopharyngeal carcinoma.
Yee KK; Soo KC; Olivo M
Int J Mol Med; 2005 Dec; 16(6):993-1002. PubMed ID: 16273277
[TBL] [Abstract][Full Text] [Related]
2. Effect of hypericin-mediated photodynamic therapy on the expression of vascular endothelial growth factor in human nasopharyngeal carcinoma.
Bhuvaneswari R; Gan YY; Yee KK; Soo KC; Olivo M
Int J Mol Med; 2007 Oct; 20(4):421-8. PubMed ID: 17786271
[TBL] [Abstract][Full Text] [Related]
3. Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models.
Zhou Q; Olivo M; Lye KY; Moore S; Sharma A; Chowbay B
Cancer Chemother Pharmacol; 2005 Dec; 56(6):569-77. PubMed ID: 16001166
[TBL] [Abstract][Full Text] [Related]
4. Hypericin-mediated photodynamic therapy in combination with Avastin (bevacizumab) improves tumor response by downregulating angiogenic proteins.
Bhuvaneswari R; Yuen GY; Chee SK; Olivo M
Photochem Photobiol Sci; 2007 Dec; 6(12):1275-83. PubMed ID: 18046482
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenesis agents avastin and erbitux enhance the efficacy of photodynamic therapy in a murine bladder tumor model.
Bhuvaneswari R; Yuen GY; Chee SK; Olivo M
Lasers Surg Med; 2011 Sep; 43(7):651-62. PubMed ID: 22057493
[TBL] [Abstract][Full Text] [Related]
6. Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors.
Ferrario A; Fisher AM; Rucker N; Gomer CJ
Cancer Res; 2005 Oct; 65(20):9473-8. PubMed ID: 16230411
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic investigation and implications of photodynamic therapy induction of vascular endothelial growth factor in prostate cancer.
Solban N; Selbo PK; Sinha AK; Chang SK; Hasan T
Cancer Res; 2006 Jun; 66(11):5633-40. PubMed ID: 16740700
[TBL] [Abstract][Full Text] [Related]
8. Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma.
Ferrario A; von Tiehl KF; Rucker N; Schwarz MA; Gill PS; Gomer CJ
Cancer Res; 2000 Aug; 60(15):4066-9. PubMed ID: 10945611
[TBL] [Abstract][Full Text] [Related]
9. Biodistribution and photodynamic therapy with hypericin in a human NPC murine tumor model.
Du HY; Bay BH; Olivo M
Int J Oncol; 2003 May; 22(5):1019-24. PubMed ID: 12684667
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of hypericin-mediated photodynamic therapy in combination with angiogenesis inhibitor bevacizumab using in vivo fluorescence confocal endomicroscopy.
Bhuvaneswari R; Thong PS; Gan YY; Soo KC; Olivo M
J Biomed Opt; 2010; 15(1):011114. PubMed ID: 20210440
[TBL] [Abstract][Full Text] [Related]
11. Hypericin-photodynamic therapy (PDT) using an alternative treatment regime suitable for multi-fraction PDT.
Thong PS; Watt F; Ren MQ; Tan PH; Soo KC; Olivo M
J Photochem Photobiol B; 2006 Jan; 82(1):1-8. PubMed ID: 16203156
[TBL] [Abstract][Full Text] [Related]
12. Photoactivation of hypericin down-regulates glutathione S-transferase activity in nasopharyngeal cancer cells.
Du HY; Olivo M; Tan BK; Bay BH
Cancer Lett; 2004 Apr; 207(2):175-81. PubMed ID: 15072826
[TBL] [Abstract][Full Text] [Related]
13. Hypericin-mediated photodynamic therapy elicits differential interleukin-6 response in nasopharyngeal cancer.
Du H; Bay BH; Mahendran R; Olivo M
Cancer Lett; 2006 Apr; 235(2):202-8. PubMed ID: 15935550
[TBL] [Abstract][Full Text] [Related]
14. Hypericin-mediated photodynamic therapy induces lipid peroxidation and necrosis in nasopharyngeal cancer.
Du HY; Olivo M; Tan BK; Bay BH
Int J Oncol; 2003 Nov; 23(5):1401-5. PubMed ID: 14532982
[TBL] [Abstract][Full Text] [Related]
15. Molecular profiling of angiogenesis in hypericin mediated photodynamic therapy.
Bhuvaneswari R; Gan YY; Lucky SS; Chin WW; Ali SM; Soo KC; Olivo M
Mol Cancer; 2008 Jun; 7():56. PubMed ID: 18549507
[TBL] [Abstract][Full Text] [Related]
16. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
Wang L; Chen W; Xie X; He Y; Bai X
Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of photodynamic therapy by 2,5-dimethyl celecoxib, a non-cyclooxygenase-2 inhibitor analog of celecoxib.
Ferrario A; Lim S; Xu F; Luna M; Gaffney KJ; Petasis NA; Schönthal AH; Gomer CJ
Cancer Lett; 2011 May; 304(1):33-40. PubMed ID: 21339042
[TBL] [Abstract][Full Text] [Related]
18. In vivo photodynamic activity of hypericin in transitional cell carcinoma bladder tumors.
Zupkó I; Kamuhabwa AR; D'Hallewin MA; Baert L; De Witte PA
Int J Oncol; 2001 May; 18(5):1099-105. PubMed ID: 11295062
[TBL] [Abstract][Full Text] [Related]
19. Expression of Y-Box binding protein-1 following hypericin-mediated photodynamic therapy in well-differentiated nasopharyngeal cancer in vivo.
Du HY; Olivo M; Chen YJ; Yip G; Tan PH; Matsumoto K; Tsujimoto M; Bay BH
Int J Mol Med; 2005 Nov; 16(5):865-8. PubMed ID: 16211256
[TBL] [Abstract][Full Text] [Related]
20. Plasma levels of vascular endothelial growth factor during and after radiotherapy in combination with celecoxib in patients with advanced head and neck cancer.
Halamka M; Cvek J; Kubes J; Zavadova E; Kominek P; Horacek J; Dusek L; Feltl D
Oral Oncol; 2011 Aug; 47(8):763-7. PubMed ID: 21696999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
